
Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics' technology leverages massive gains in print speed and resolution to break the microvasculature barrier. The company was founded in 2016 and is based in San Francisco, California.

Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics' technology leverages massive gains in print speed and resolution to break the microvasculature barrier. The company was founded in 2016 and is based in San Francisco, California.
Founded: 2016
Headquarters: San Francisco / Berkeley, CA area
Tech focus: 3D bioprinted lymph node organoids + AI/ML for antibody discovery (EXIS™)
Recent funding: Series C activity recorded (latest date Mar 10, 2025)
Antibody discovery and therapeutic development using human-relevant in vitro models; long-term organ engineering for transplantation.
2016
Biotechnology Research
14,500,000
Series B reported at $14.5M; participation from Khosla Ventures and SOSV/IndieBio
Series C activity recorded with announced date Mar 10, 2025
“Backed by institutional VCs including Celesta Capital, Khosla Ventures, SOSV/IndieBio, Avidity Partners, True Ventures, Black Diamond Ventures and others”
| Company |
|---|
The heart of Prellis Bio’s strategy is the combination of novel, cutting edge methods in machine learning, biology at scale and next gen antibody discovery that address long-standing industry-wide problems in the drug development pipeline. Prellis Biologics uses proprietary technology to 3D print human lymph node organoids enabling the rapid & diverse discovery of human antibody therapeutic candidates for a range of applications.To drive this forward, we are assembling an incredible team of discovery biologists, computational scientists, and protein scientists who want to make a difference to this important problem.
Our Next-Generation Sequencing (NGS) group isseeking a motivated and energetic Associate NGS Scientist to join our team. at the junction of andbiologics discovery. The qualified candidate will be hands-on in molecular biology, responsible forexecuting cutting-edgeNGS workflows, and eager to work in a dynamic, cross-functional environment focused on rapid antibody candidate identification.
Responsibilities
Qualifications
Preferred Experience
About Prellis Biologics At Prellis, we integrate human biology with machine learning. We aim to revolutionize drug discovery by harnessing the power of the human immune system to develop next-generation antibody therapeutics with unparalleled speed, precision, and safety. We are committed to empowering our pharmaceutical partners with access to the most promising, fully human antibody candidates rapidly identified from the human immune repertoire.
Prellis Biologics is a pre-IPO biotech located in Berkeley, CA, with a team-oriented, inclusive, and family-friendly culture. Our growing pipeline targets high unmet patient needs across therapeutic areas, including metabolic, inflammation, and oncology diseases. Our investors include Celesta, Khosla Ventures, SOSV, and Avidity Partners.
What You Can Expect From Us As we work to develop treatments that take care of others, we also care for your professional and personal growth and well-being. From our collaborative culture to opportunities for learning and impact, you’ll be supported every step of the way.
Actual salary will vary based on several factors including but not limited to, relevant skills, experience, and qualifications.
Benefits Benefits In addition to the base salary, Prellis offers compelling benefits based on eligibility, comprising of health and welfare plans for staff and eligible dependents, financial plans with opportunities to save towards retirement or other goals, work/life balance, and career development opportunities that may include:
Application deadline Prellis does not have an application deadline for this position; we will continue accepting applications until we receive a sufficient number or select a candidate for the position.
Prellis Bio is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.
We believe diversity, equity, and inclusion need to be at the foundation of our culture. We work hard to bring together diverse teams–grounded in a wide range of expertise and life experiences–and work even harder to ensure those teams thrive in inclusive, growth-oriented environments supported by equitable company and team practices. All candidates can expect equitable treatment, respect, and fairness throughout the interview process.